Clinical Trials Browser

Phase 2 × Glioblastoma × carotuximab × Clear all

NCT01564914 2019-06-12

105GM201

Phase 2 Completed

22 enrolled 11 charts

Glioblastoma

NCT01778530 2015-10-07

TRC105 for Recurrent Glioblastoma

Phase 2 Terminated

2 enrolled 9 charts

Glioblastoma, Glioma, Disease Progression